Astera Labs (NASDAQ:ALAB) Stock Price Up 7.6% – What’s Next?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) were up 7.6% during trading on Tuesday. The company traded as high as $401.74 and last traded at $389.80. Approximately 6,489,137 shares traded hands during trading, an increase of 25% from the average session volume of 5,191,556 shares. The stock had previously closed at $362.34.

Analysts Set New Price Targets

A number of research analysts recently issued reports on ALAB shares. Morgan Stanley lifted their price target on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Needham & Company LLC upped their price target on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Stifel Nicolaus lifted their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Finally, TD Cowen cut their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research note on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $348.33.

Astera Labs Price Performance

The firm has a 50-day moving average of $310.63 and a 200 day moving average of $284.74. The company has a market capitalization of $67.62 billion, a PE ratio of 192.97 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter in the prior year, the business earned $0.44 EPS. The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insider Activity at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the sale, the general counsel owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. This represents a 6.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 396,059 shares of company stock valued at $122,605,660 in the last 90 days. 10.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds have recently modified their holdings of ALAB. Greenleaf Trust increased its stake in Astera Labs by 1.8% in the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after acquiring an additional 36 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in shares of Astera Labs by 74.5% in the second quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock valued at $46,000 after purchasing an additional 41 shares in the last quarter. Glenmede Trust Co. NA grew its holdings in shares of Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares in the last quarter. Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs during the second quarter valued at $25,000. Finally, Integrated Wealth Concepts LLC lifted its position in Astera Labs by 0.7% during the second quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock valued at $3,384,000 after purchasing an additional 52 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.